Medicine & Life Sciences
Nanoparticles
88%
Genetic Therapy
87%
Small Interfering RNA
64%
Lipids
63%
Glaucoma
56%
Trabecular Meshwork
51%
Clinical Trials
50%
Cystic Fibrosis Transmembrane Conductance Regulator
48%
Fibrosis
45%
Exosomes
45%
Ophthalmology
43%
Minimally Invasive Surgical Procedures
43%
Transfection
39%
RNA
39%
Cystic Fibrosis
37%
Messenger RNA
36%
Fibroblasts
33%
ISTH0036
33%
PF-04523655
30%
Gene Silencing
27%
Eye Diseases
26%
Regulator Genes
26%
Safety
22%
myocardin
22%
Therapeutics
21%
DNA
21%
Peptides
21%
Gene Editing
20%
Pharmaceutical Preparations
18%
Retinal Diseases
15%
Dry Eye Syndromes
15%
Antisense Oligonucleotides
14%
Macular Edema
14%
Mutation
14%
Genes
14%
Macular Degeneration
13%
Eye
12%
RNA Interference
12%
Serum Response Factor
11%
Filtering Surgery
10%
Transcription Factors
10%
In Vitro Techniques
9%
Technology
8%
Aqueous Humor
7%
Hepatocytes
6%
Animals
6%
Collagen
5%
Chemical Compounds
Silencing RNA
100%
Conjunctival
80%
Cryoprotective Agent
55%
Lipid
54%
Nanoparticle
52%
Encapsulation
41%
Antifibrotic
33%
Safety
33%
Peptide
22%
Mutation
21%
Intraocular
13%
Small Interfering RNA
13%
Cell Viability
9%
Collagen
9%
Filtration
8%
Drug
6%
Messenger RNA
5%